Back to Search
Start Over
Quality prescribing in early psychosis: key pharmacotherapy principles.
- Source :
-
Australasian Psychiatry . Jun2022, Vol. 30 Issue 3, p341-345. 5p. - Publication Year :
- 2022
-
Abstract
- Objective: To present a practical, easy-to-implement clinical framework designed to support evidence-based quality prescribing for people with early psychosis. Method: Identification and explanation of key principles relating to evidence-based pharmacotherapy for people with early psychosis. These were derived from the literature, practice guidelines and clinical experience. Results: Key principles include (1) medication choice informed by adverse effects; (2) metabolic monitoring at baseline and at regular intervals; (3) comprehensive and regular medication risk–benefit assessment and psychoeducation; (4) early consideration of long-acting injectable formulations (preferably driven by informed patient choice); (5) identification and treatment of comorbid mood disorders and (6) early consideration of clozapine when treatment refractory criteria are met. Conclusions: Current prescribing practices do not align with the well-established evidence for quality pharmacotherapy in early psychosis. Adopting evidence-based prescribing practices for people with early psychosis will improve outcomes. [ABSTRACT FROM AUTHOR]
- Subjects :
- *PSYCHOSES
*DRUG therapy
*AFFECTIVE disorders
*PSYCHOEDUCATION
*CLOZAPINE
Subjects
Details
- Language :
- English
- ISSN :
- 10398562
- Volume :
- 30
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Australasian Psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 157265013
- Full Text :
- https://doi.org/10.1177/10398562211054656